Short Bowel Syndrome Market Size and Share is Anticipated to Surge During the Study Period (2020–2034) | DelveInsight
February 22, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Short Bowel Syndrome Market Size and Share is Anticipated to Surge During the Study Period (2020–2034) | DelveInsight The dynamics of the short...
Zealand Pharma submits New Drug Application to the US FDA for glepaglutide in short bowel syndrome
December 22, 2023 04:30 ET
|
Zealand Pharma
Press release – No. 18 / 2023 Zealand Pharma submits New Drug Application to the US FDA for glepaglutide in short bowel syndrome Copenhagen, Denmark, December 22, 2023 – Zealand Pharma A/S...
Zealand Pharma to Participate in 22nd Annual Needham Virtual Healthcare Conference
April 12, 2023 11:00 ET
|
Zealand Pharma
Press release – No. 2 / 2023 Zealand Pharma to Participate in 22nd Annual Needham Virtual Healthcare Conference Copenhagen, Denmark, April 12, 2023 – Zealand Pharma A/S (Nasdaq...
With 14.4% CAGR, Short Bowel Syndrome Market Size to Surpass Around USD 2,213.5 Billion by 2029
December 19, 2022 06:48 ET
|
Fortune Business Insights
Pune, India, Dec. 19, 2022 (GLOBE NEWSWIRE) -- The short bowel syndrome market size was valued at USD 737.9 million in 2021. It is projected to reach from USD 865.3 million in 2022 to USD 2,213.5...
VectivBio Appoints Patrick Malloy as Senior Vice President, Investor Relations & Strategic Communications
April 21, 2022 07:15 ET
|
VectivBio AG
BASEL, Switzerland, April 21, 2022 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for...
VectivBio Announces Third Quarter 2021 Business Update
November 10, 2021 08:30 ET
|
VectivBio AG
-Pivotal STARS Program of Apraglutide in SBS-IF Progressing with Majority of Sites Activated and Screening; STARS Nutrition Interim Results Expected 1H 2022- -Expanded Rare Disease Pipeline with...
VectivBio Publishes Invitation to the Extraordinary General Meeting
August 12, 2021 07:15 ET
|
VectivBio AG
BASEL, Switzerland, Aug. 12, 2021 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company focused on the discovery, development and...
VectivBio Nominates Paul R. Carter and Murray W. Stewart for Election to its Board of Directors
July 12, 2021 07:15 ET
|
VectivBio AG
- Industry veterans bring decades of clinical, regulatory and commercial management expertise to VectivBio - - Nominees will stand for election at an Extraordinary General Meeting of shareholders on...
Zealand Pharma introduces new website to support people living with short bowel syndrome
June 21, 2019 03:00 ET
|
Zealand Pharma
Press release – No. 15 / 2019 Zealand Pharma introduces new website to support people living with short bowel syndrome LivingWithSBS.com is a new website with information about short bowel syndrome,...